Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04875364 · ClinicalTrials.gov registry record · Phase 2
Do Endotypes Predict Response and Sequelae in OSA Patients
A Phase 2 study of Obstructive Sleep Apnea and Sleep, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04875364: Recruiting Phase 2 study of Obstructive Sleep Apnea and Sleep, sponsored by University of California, San Diego.
NCT04875364 is a Phase 2 study of Obstructive Sleep Apnea and Sleep that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 200 participants, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04875364, a Phase 2 study of Obstructive Sleep Apnea and Sleep, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate why some people have Obstructive Sleep Apnea (OSA) and how the underlying cause may relate to OSA manifestations (including sleepiness and high blood pressure) and response to different therapeutic approaches (ie CPAP, eszopiclone, and supplemental oxygen). Understanding why someone has OSA could affect how best to treat that individual, but may also have an impact on what problems the disease might cause.
Primary Outcome
A 10-minutes, computerized reaction test asking subject to press a button every time a prompt appears. Faster times indicate better reactions and higher alertness.
Conditions Studied
Interventions
- DRUG Eszopiclone
- OTHER Supplemental Oxygen
- DEVICE Continuous Positive Airway Pressure (CPAP)
Study Locations (1)
California
- Altman Clinical and Translational Research Institute Building - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2027-01-01 |
| Phase | Phase 2 |
What NCT04875364 shows while recruiting
NCT04875364 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target.
The record links to 5 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 3 interventions - of which Eszopiclone is the first listed.
NCT04875364 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04875364 about?
NCT04875364 is a clinical study titled "Do Endotypes Predict Response and Sequelae in OSA Patients". This study will investigate why some people have Obstructive Sleep Apnea (OSA) and how the underlying cause may relate to OSA manifestations (including sleepiness and high blood pressure) and response to different therapeutic approaches (ie CPAP, eszopiclone, and supplemental oxygen). Understanding ...
What is the current status of trial NCT04875364?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2020-08-01. Estimated completion is 2027-01-01.
What conditions does trial NCT04875364 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Sleep, Sleep Apnea, Obstructive, Sleep Apnea, Sleep Disorder.
What interventions are being tested in trial NCT04875364?
The interventions under investigation include: Eszopiclone (DRUG), Supplemental Oxygen (OTHER), Continuous Positive Airway Pressure (CPAP) (DEVICE).
Who is sponsoring clinical trial NCT04875364?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04875364 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04875364's enrollment target sits among peer trials
200 39th of 155 higher than 113 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RECRUITING · Phase 2
-
Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome
RECRUITING · Phase 2
-
Down Syndrome Obstructive Sleep Apnea
RECRUITING · Phase 2
-
Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea
RECRUITING · Phase 2
-
Endotypic Traits and Obstructive Sleep Apnea Surgery
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI